Latest News - Phase 3/4 Trials

Monday, April 30, 2018 | Phase 3/4 Trials, PracticalDermatology.com, Research and Publications

Jury Still Out on Cosmetic Uses of PRP

Most studies evaluating platelet-rich plasma (PRP) injection for facial rejuvenation and other cosmetic procedures have reported positive results, but the research evidence supporting PRP for facial a…

Read the full story

Monday, February 12, 2018 | Phase 3/4 Trials, PracticalDermatology.com, Product Launches and Updates

Denova Research Partners with Illinois Dermatology Institute

DeNova Research is partnering with Illinois Dermatology Institute to become one of the largest and most comprehensive Dermatologic and Cosmetic Clinical Research sites in the Midwest. Denova Resear…

Read the full story

Tuesday, December 05, 2017 | Phase 3/4 Trials, PracticalDermatology.com, Research and Publications

Investigational Neurotoxin Achieves 6-Month Duration in Phase 3: Revance

Revance Therapeutics’ next-generation neuromodulator DaxibotulinumtoxinA for Injection (RT002) delivered positive top-line results in alleviating moderate-to-severe glabellar lines in two pivota…

Read the full story

Thursday, April 06, 2017 | Phase 3/4 Trials, PracticalDermatology.com, Galderma

Restylane® Refyne and Restylane® Defyne Show Lasting Natural Benefit in Phase 4 Studies

Two Phase 4 clinical studies of Restylane® Refyne and Restylane® Defyne show that the natural-looking results last. Specifically, the Natural Expression study found that…

Read the full story